By monitoring CRP levels and NLR during clozapine titration, clinicians can detect subclinical inflammation early and take measures such as temporarily halting titration, thereby preventing the progression of clozapine-induced life-threatening conditions such as myocarditis, pneumonia, and DRESS syndrome. Here, CRP is linked to pneumonia.